Find Povorcitinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Povorcitinib [inn], N0jwc7ro00, (s)-4-(3-(cyanomethyl)-3-(3',5'-dimethyl-1h,1'h-(4,4'-bipyrazol)-1-yl)azetidin-1-yl)-2,5-difluoro-n-(1,1,1-trifluoropropan-2-yl)benzamide, 1637677-22-5, 4-(3-(cyanomethyl)-3-(3',5'-dimethyl-1h,1'h-4,4'-bipyrazol-1-yl)azetidin-1-yl)-2,5-difluoro-n-((1s)-2,2,2-trifluoro-1-methylethyl)benzamide, 4-[3-(cyanomethyl)-3-(3',5'-dimethyl-1h,1'h-4,4'-bipyrazol-1-yl) azetidin-1-yl]-2,5-difluoro-n-[(1s)-2,2,2-trifluoro-1-methylethyl]benzamide
Molecular Formula
C23H22F5N7O
Molecular Weight
507.5  g/mol
InChI Key
MSGYSFWCPOBHEV-AWEZNQCLSA-N
FDA UNII
N0JWC7RO00

Povorcitinib
1 2D Structure

Povorcitinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[3-(cyanomethyl)-3-[4-(3,5-dimethyl-1H-pyrazol-4-yl)pyrazol-1-yl]azetidin-1-yl]-2,5-difluoro-N-[(2S)-1,1,1-trifluoropropan-2-yl]benzamide
2.1.2 InChI
InChI=1S/C23H22F5N7O/c1-12-20(13(2)33-32-12)15-8-30-35(9-15)22(4-5-29)10-34(11-22)19-7-17(24)16(6-18(19)25)21(36)31-14(3)23(26,27)28/h6-9,14H,4,10-11H2,1-3H3,(H,31,36)(H,32,33)/t14-/m0/s1
2.1.3 InChI Key
MSGYSFWCPOBHEV-AWEZNQCLSA-N
2.1.4 Canonical SMILES
CC1=C(C(=NN1)C)C2=CN(N=C2)C3(CN(C3)C4=C(C=C(C(=C4)F)C(=O)NC(C)C(F)(F)F)F)CC#N
2.1.5 Isomeric SMILES
CC1=C(C(=NN1)C)C2=CN(N=C2)C3(CN(C3)C4=C(C=C(C(=C4)F)C(=O)N[C@@H](C)C(F)(F)F)F)CC#N
2.2 Other Identifiers
2.2.1 UNII
N0JWC7RO00
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Povorcitinib [inn]

2. N0jwc7ro00

3. (s)-4-(3-(cyanomethyl)-3-(3',5'-dimethyl-1h,1'h-(4,4'-bipyrazol)-1-yl)azetidin-1-yl)-2,5-difluoro-n-(1,1,1-trifluoropropan-2-yl)benzamide

4. 1637677-22-5

5. 4-(3-(cyanomethyl)-3-(3',5'-dimethyl-1h,1'h-4,4'-bipyrazol-1-yl)azetidin-1-yl)-2,5-difluoro-n-((1s)-2,2,2-trifluoro-1-methylethyl)benzamide

6. 4-[3-(cyanomethyl)-3-(3',5'-dimethyl-1h,1'h-4,4'-bipyrazol-1-yl) Azetidin-1-yl]-2,5-difluoro-n-[(1s)-2,2,2-trifluoro-1-methylethyl]benzamide

7. Benzamide, 4-(3-(cyanomethyl)-3-(3',5'-dimethyl(4,4'-bi-1h-pyrazol)-1-yl)-1-azetidinyl)-2,5-difluoro-n-((1s)-2,2,2-trifluoro-1-methylethyl)-

8. 4-[3-(cyanomethyl)-3-(3',5'-dimethyl-1h,1'h-4,4'-bipyrazol-1-yl)azetidin-1-yl]-2,5-difluoro-n-[(1s)-2,2,2-trifluoro-1-methylethyl]benzamide

9. Unii-n0jwc7ro00

10. Schembl16240136

11. Gtpl11881

12. Compound 7 [us20210238168a1]

13. Hy-145588

14. Cs-0376529

15. 4-[3-(cyanomethyl)-3-[4-(3,5-dimethyl-1h-pyrazol-4-yl)pyrazol-1-yl]azetidin-1-yl]-2,5-difluoro-n-[(2s)-1,1,1-trifluoropropan-2-yl]benzamide

2.4 Create Date
2014-12-08
3 Chemical and Physical Properties
Molecular Weight 507.5 g/mol
Molecular Formula C23H22F5N7O
XLogP33.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count10
Rotatable Bond Count6
Exact Mass507.18059916 g/mol
Monoisotopic Mass507.18059916 g/mol
Topological Polar Surface Area103 Ų
Heavy Atom Count36
Formal Charge0
Complexity860
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty